Irrational Exuberance in Testosterone Prescribing
When Will the Bubble Burst
Bibliographic Data
| ID | 9103628 |
|---|---|
| Authors | David J Handelsman (0000-0002-4200-7476, Anzac Research Institute, corresponding author) |
| Year | 2015 |
| Volume | 53 |
| Issue | 9 |
| Pages | 743-745 |
| Publication date | 2015-09-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/mlr.0000000000000416 |
| PMID | 26270825 |
| OpenAlex | W2465824810 |
| Language | EN |
| References cited | 20 |
ANZAC Research Institute, University of Sydney, Concord Hospital, NSW, Australia D.J.H.’s institution gets pharmaceutical company funding (Besin, Lawley) for investigator-initiated studies in testosterone pharmacology. The author receives no personal income or consultancy fees related to this work. Reprints: David J. Handelsman, MBBS, FRACP, PhD, ANZAC Research Institute, University of Sydney, Concord Hospital, NSW 2139, Australia. E-mail: [email protected]
Family medicine · Institution · Irrational number · Medical education · Political science · Testosterone (patch) · Hormonal and reproductive studies · Internal Medicine · Law · Medicine · Pharmacogenetics and Drug Metabolism · Pharmacology and Obesity Treatment · Psychology
| Citation velocity | historical |
|---|---|
| Highly cited | No |